DCF — MERCYONE - NEWTON MEDICAL CENTER
Enterprise Value: $-90.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-90.3M
Enterprise Value
$-27.9M
PV of Cash Flows
$-62.4M
PV of Terminal Value
$-100.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $35.6M | $-6.0M | -17.0% | $-7.5M | $-6.8M |
| Year 2 | $36.7M | $-5.8M | -16.0% | $-7.4M | $-6.1M |
| Year 3 | $37.7M | $-5.6M | -15.0% | $-7.2M | $-5.4M |
| Year 4 | $38.9M | $-5.6M | -14.0% | $-7.2M | $-4.9M |
| Year 5 | $40.0M | $-5.7M | -14.0% | $-7.4M | $-4.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-90.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$34.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17381179295513735
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5